Cargando…

Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service

SUMMARY: In this cross-sectional study, two-thirds of Fracture Liaison Service (FLS) patients had comorbidities and medications associated with increased bone- or fall-related fracture risk. Bone-related and fall-related fracture risk (BRR and FRR) were associated with age and fracture type, but not...

Descripción completa

Detalles Bibliográficos
Autores principales: Vranken, L., Wyers, C. E., Van der Velde, R. Y., Janzing, H. M., Kaarsemaker, S., Geusens, P. P., Van den Bergh, J. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818578/
https://www.ncbi.nlm.nih.gov/pubmed/29170857
http://dx.doi.org/10.1007/s00198-017-4290-y
_version_ 1783301052245737472
author Vranken, L.
Wyers, C. E.
Van der Velde, R. Y.
Janzing, H. M.
Kaarsemaker, S.
Geusens, P. P.
Van den Bergh, J. P.
author_facet Vranken, L.
Wyers, C. E.
Van der Velde, R. Y.
Janzing, H. M.
Kaarsemaker, S.
Geusens, P. P.
Van den Bergh, J. P.
author_sort Vranken, L.
collection PubMed
description SUMMARY: In this cross-sectional study, two-thirds of Fracture Liaison Service (FLS) patients had comorbidities and medications associated with increased bone- or fall-related fracture risk. Bone-related and fall-related fracture risk (BRR and FRR) were associated with age and fracture type, but not with gender or BMD. Systematic evaluation of these factors leads to a more profound assessment in FLS care. INTRODUCTION: This study is a systematic evaluation of comorbidities and medications associated with increased fracture risk in patients aged 50–90 years with a recent fracture visiting the FLS. METHODS: In this cross-sectional cohort study, comorbidities were classified according to ICD-10 and medications according to the Anatomic Therapeutic Chemical (ATC) classification and further categorized into those associated BRR and FRR. RESULTS: Of 1282 patients (72% women; 65 ± 9 years), 53% had at least one BRR, 46% had at least one FRR, and 66% at least one BRR and/or FRR. At least one BRR, as well as at least one FRR were associated with age, BMI, and fracture type, but not with gender or BMD. The proportion of patients with only BRR (± 20%) or only FRR (± 10%) was similar among ages, gender, BMI, fracture type, and BMD. The combination of at least one BRR and at least one FRR was significantly associated with age, BMI, and major fractures, but not with gender or BMD. CONCLUSION: Comorbidities and medications associated with increased fracture risk are present in two-thirds of patients visiting the FLS. In addition, the proportion of patients having a combination of BRR and FRR increased significantly with age, BMI, and fracture severity. This indicates that systematic evaluation of these factors is important for a more profound assessment of subsequent fracture risk in FLS care. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00198-017-4290-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5818578
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-58185782018-02-27 Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service Vranken, L. Wyers, C. E. Van der Velde, R. Y. Janzing, H. M. Kaarsemaker, S. Geusens, P. P. Van den Bergh, J. P. Osteoporos Int Original Article SUMMARY: In this cross-sectional study, two-thirds of Fracture Liaison Service (FLS) patients had comorbidities and medications associated with increased bone- or fall-related fracture risk. Bone-related and fall-related fracture risk (BRR and FRR) were associated with age and fracture type, but not with gender or BMD. Systematic evaluation of these factors leads to a more profound assessment in FLS care. INTRODUCTION: This study is a systematic evaluation of comorbidities and medications associated with increased fracture risk in patients aged 50–90 years with a recent fracture visiting the FLS. METHODS: In this cross-sectional cohort study, comorbidities were classified according to ICD-10 and medications according to the Anatomic Therapeutic Chemical (ATC) classification and further categorized into those associated BRR and FRR. RESULTS: Of 1282 patients (72% women; 65 ± 9 years), 53% had at least one BRR, 46% had at least one FRR, and 66% at least one BRR and/or FRR. At least one BRR, as well as at least one FRR were associated with age, BMI, and fracture type, but not with gender or BMD. The proportion of patients with only BRR (± 20%) or only FRR (± 10%) was similar among ages, gender, BMI, fracture type, and BMD. The combination of at least one BRR and at least one FRR was significantly associated with age, BMI, and major fractures, but not with gender or BMD. CONCLUSION: Comorbidities and medications associated with increased fracture risk are present in two-thirds of patients visiting the FLS. In addition, the proportion of patients having a combination of BRR and FRR increased significantly with age, BMI, and fracture severity. This indicates that systematic evaluation of these factors is important for a more profound assessment of subsequent fracture risk in FLS care. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00198-017-4290-y) contains supplementary material, which is available to authorized users. Springer London 2017-11-23 2018 /pmc/articles/PMC5818578/ /pubmed/29170857 http://dx.doi.org/10.1007/s00198-017-4290-y Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Vranken, L.
Wyers, C. E.
Van der Velde, R. Y.
Janzing, H. M.
Kaarsemaker, S.
Geusens, P. P.
Van den Bergh, J. P.
Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service
title Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service
title_full Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service
title_fullStr Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service
title_full_unstemmed Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service
title_short Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service
title_sort comorbidities and medication use in patients with a recent clinical fracture at the fracture liaison service
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818578/
https://www.ncbi.nlm.nih.gov/pubmed/29170857
http://dx.doi.org/10.1007/s00198-017-4290-y
work_keys_str_mv AT vrankenl comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice
AT wyersce comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice
AT vanderveldery comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice
AT janzinghm comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice
AT kaarsemakers comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice
AT geusenspp comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice
AT vandenberghjp comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice